Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05135195 · ClinicalTrials.gov registry record · NA
A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT05135195 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 98 participants.
The verdict
NCT05135195, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
In this study, the study team utilize virtual reality (VR) to simulate visual impairments of different types and severity in healthy subjects. The platform implements three of the most widespread forms of visual impairment in the United States (US): age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma, each with three levels of severity, (mild, moderate, and severe). At present, glaucoma is further developed toward a multidimensional visual impairment simulation. The platform is utilized: i) to provide a safe, controllable, and repeatable set of environments for development and preliminary testing of electronic travel aids (ETAs) in a variety of conditions (i.e., using the ETA to navigate in the immersed environment); and ii) to equip blind and low vision (BVI) professionals, inclusive of orientation and mobility (O\&M) instructors, with a controlled, tunable training platform for skill/capacity building, assessment, and refinement of O\&M techniques, as well as visually impaired trainees with a safe and immersive environment to improve their O\&M skills and learn novel techniques. Two sets of hypothesis-driven experiments are proposed to assess the feasibility of the platform with respect to these two objectives.
Interventions
- OTHER In-House Developed VR Platform - AMD, DR, Glaucoma
- OTHER In-House Developed VR Platform - Glaucoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2021-10-24 |
| Est. Completion | 2022-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05135195
The ClinicalTrials.gov registry entry for NCT05135195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which In-House Developed VR Platform - AMD, DR, Glaucoma is the first listed.
NCT05135195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05135195 about?
NCT05135195 is a clinical study titled "A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training". In this study, the study team utilize virtual reality (VR) to simulate visual impairments of different types and severity in healthy subjects. The platform implements three of the most widespread forms of visual impairment in the United States (US): age-related macular degeneration (AMD), diabetic r...
What is the current status of trial NCT05135195?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2021-10-24. Estimated completion is 2022-10-20.
What interventions are being tested in trial NCT05135195?
The interventions under investigation include: In-House Developed VR Platform - AMD, DR, Glaucoma (OTHER), In-House Developed VR Platform - Glaucoma (OTHER).
Who is sponsoring clinical trial NCT05135195?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.